Category: 8. Health

  • How early immune challenges influence oral and systemic health in children

    How early immune challenges influence oral and systemic health in children

    Once viewed only as infectious invaders, bacteria are now understood to play an important role in overall health. For example, the gut microbiome-the community of microorganisms that inhabit the human gastrointestinal tract-has garnered much attention recently as studies have explored its relationship with health and disease.

    But what about the mouth? The mouth is the second most diverse human microbial system and, as the start of the digestive system, is directly and frequently exposed to the external environment. However, it has been vastly overshadowed by the focus on the gut.

    Now, a collaborative team including Modupe O. Coker of Penn Dental Medicine has investigated the stability of the oral microbiome in children living with HIV and those exposed to the virus but uninfected. Their findings, published in Microbiome, challenge the conventional belief that a stable microbiome is important for overall health and offer insights into how early immune challenges shape not only oral health but also systemic health.

    “Mouth microbes are central to health-they are the first to encounter food, promoting digestion and nutrient uptake,” says Coker, assistant dean of clinical and translational research and co-senior author of the study. “But bacteria in the mouth don’t stay in the mouth-they extend to the rest of the body, influencing system health and vice versa.”

    The researchers collected supragingival, or above the gum line, plaque samples across three time points from children in Nigeria. This included children living with HIV, children perinatally exposed to HIV but uninfected by the virus, and children not exposed to and therefore uninfected by the virus. All children living with HIV were receiving highly active antiretroviral treatment (HAART) at the time of the study.

    “This population is near and dear to us all,” says Coker, adding that studying these groups of children offers the opportunity to better understand how challenges to the immune system early in life affect the oral microbiome and how that, in turn, affects other measures of development like growth and cognitive function.

    The research team mapped the spatial (front-to-back) distribution of the microbial communities in the mouth and determined the association of HIV status and cavity- or caries-related bacterial species and intraspecies variants. They also calculated the degree of taxonomic turnover across the three time points within each group.

    “[Taxonomic turnover] is measuring the entire microbial community at one time and then [measuring] the same community at a separate time and seeing how divergent they are from each other,” explains Allison E. Mann, an assistant professor of biological anthropology at the University of Wyoming and the first author on the study. “The more divergent, the higher the taxonomic turnover or volatility, and the less, the lower.”

    In the gut, continues Mann, taxonomic stability over time is good, “that’s what you want in the gut.”

    But, as this study showed, the opposite was true in the mouth-children unexposed and therefore uninfected by HIV exhibited higher turnover over time than those who had been exposed to HIV, suggesting, says Mann, that the oral microbiomes of children exposed to HIV might be less able to adapt to changes in environmental conditions or “disruptions.”

    “The idea is that because the oral microbiome has evolved to be able to live in our mouths and is obviously just constantly being bombarded with food and the like-it’s evolved a different strategy than the gut, which is relatively protected,” says Mann. “It has evolved to fluctuate and adapt to changing situations.”

    “This seems very reasonable,” says Coker. “The children in this study are in their adolescence, experiencing a lot of changes in their bodies [such as] developmental and hormonal changes, including being in a mixed dentition phase where they have primary teeth along with permanent teeth. We expect the microbiome to change, so when it doesn’t, that signals impaired adaptability. The fact that [the supragingival plaque microbiome] is more stable in children living with HIV actually makes sense.”

    Additionally, Coker adds, lower turnover was associated with higher frequencies of those groups of bacteria that cause cavities, increasing the risk of caries in this population.

    The study also showed that the microbial communities in children exposed to and infected by HIV were more homogeneous-the bacterial clusters in the front, or anterior, of the mouth were similar to those in the back, or posterior-than in children unexposed to HIV.

    “In normal circumstances, there are quite distinct differences between the front and the back of the mouth,” says Vincent P. Richards, an associate professor of biological sciences at Clemson University and co-senior author of the study. “And in kids living with HIV, that’s destroyed.”

    This is important, he adds, because it gets researchers closer to understanding the mechanism underlying these changes and their outcomes. “This tells us that the virus might be differentially affecting different glands and ducts differently,” he says, referring to how perinatal HIV exposure without infection as well as HIV infection and associated treatment have been linked to decreased salivary flow, and how saliva from children living with HIV presents as more acidic.

    As Coker explains, these results give a clue into the broader question of how an early-life disruption to systemic health-such as prenatal exposure to HIV-can impact the oral microbiome.

    “We know that oral microbes affect systemic health,” she says. “But systemic health also shapes oral health, so there is a cyclical relationship. And as an epidemiologist and translational scientist, I hope we can keep looking at novel ways to use this information to understand disease and to possibly prevent or treat it.”

    Source:

    University of Pennsylvania

    Journal reference:

    Mann, A. E., et al. (2025). HIV infection and exposure is associated with increased cariogenic taxa, reduced taxonomic turnover, and homogenized spatial differentiation for the supragingival microbiome. Microbiome. doi.org/10.1186/s40168-025-02123-9.

    Continue Reading

  • Understanding the biomarkers and mechanisms associated with anti-NMDAR encephalitis

    Understanding the biomarkers and mechanisms associated with anti-NMDAR encephalitis

    Encephalitis is a potentially life-threatening condition that involves inflammation of the brain. While some cases of encephalitis are caused by a bacterial or viral infection, other cases of ‘autoimmune’ encephalitis result when the body’s own immune system attacks the brain. One type of autoimmune encephalitis is characterized by antibodies (protective proteins produced by the immune system) that target N-methyl-D-aspartate (NMDA) receptors, or NMDARs, which play an important role in the transmission of signals between neurons in the nervous system.

    This type of encephalitis, known as anti-NMDAR encephalitis, typically affects younger women and children and has a higher incidence in Asian populations. In fact, around 12.9% of unexplained encephalitis cases in China were found to be cases of autoimmune encephalitis – of which 90% were anti-NMDAR encephalitis cases. Despite this, there are few reviews that discuss the biological markers that characterize anti-NMDAR encephalitis.

    To better understand the biological markers of this disease, two researchers, Dr. Honghao Wang and Dr. Minchao He from The Second Affiliated Hospital of South China University of Technology, Guangzhou, China, conducted a comprehensive review of the biomarkers and mechanisms associated with anti-NMDAR encephalitis. Their findings were made available online on May 13, 2025, and were published in Volume 1, Issue 2 of the journal Brain Network Disorders in June 2025.

    In this review, the authors begin by describing the clinical characteristics, underlying mechanisms, and related conditions associated with anti-NMDAR encephalitis. They identify eight main symptom categories commonly seen in patients: psychiatric abnormalities, seizures, memory deficits, consciousness disorders, movement dysfunction, autonomic dysregulation (malfunction of nerves that control involuntary functions like heart rate and digestion), speech disturbances, and central hypoventilation (a condition in which the brain fails to control breathing properly).

    What causes this form of encephalitis? The authors explain that it can be triggered by tumors, viral infections, and certain vaccines such as H1N1 influenza and tetanus. In affected individuals, NMDARs present on tumor cells or on the surface of neurons are mistakenly identified by the immune system as threats. This activates B cells in the lymph nodes, which multiply and migrate across the blood-brain barrier into the brain. There, they mature into plasma cells that release large amounts of antibodies targeting NMDA receptors. These antibodies interfere with normal brain signaling, resulting in the neurological and psychiatric symptoms characteristic of the disease.

    The authors then review key biomarkers that can help in diagnosing and managing anti-NMDAR encephalitis. “If clinical manifestations suggest that the patient may have anti-NMDAR encephalitis, the first step must be to check for NMDAR antibodies and their levels in the blood and cerebrospinal fluid,” explains Dr. Wang.

    If NMDA antibodies are absent or present at low levels, clinicians are advised to look for additional clinical indicators. These include uric acid, C-reactive protein, 25-hydroxyvitamin D (the primary form of vitamin D in the body), and various thyroid-related hormones in the blood. Abnormal results for these indicators can support the diagnosis. Electroencephalogram tests, which detect irregular brain activity, may also help identify the condition.

    Finally, a technique called a lumbar puncture is required to obtain a sample of cerebrospinal fluid (CSF)–a fluid that surrounds the brain and spinal cord. After the CSF is obtained, tests for other markers such as interleukins and chemokines (proteins associated with the immune system and inflammation) can be conducted depending on the equipment available. In addition, molecules such as microRNAs and circular RNAs can be used for further detection.

    “In the future, we will need to search for more anti-NMDAR encephalitis biomarkers, review controversial biomarkers, and examine the strength of the evidence for existing biomarkers–further summary and refinement of these indicators are also directions for future research,” says Dr. Wang.

    The authors hope their review will serve as a valuable resource for clinicians and researchers working to improve diagnosis and treatment of anti-NMDAR encephalitis.

    Source:

    Brain Network Disorders Editorial Office

    Journal reference:

    He, M., & Wang, H. (2025). Biomarkers on anti-N-methyl-D-aspartate receptor encephalitis. Brain Network Disorders. doi.org/10.1016/j.bnd.2025.03.001.

    Continue Reading

  • New wearable device offers real-time blood pressure monitoring

    New wearable device offers real-time blood pressure monitoring

    Seoul National University College of Engineering announced that a research team led by Professor Seung Hwan Ko of the Wearable Soft Electronics Lab, Department of Mechanical Engineering, has developed a wearable electronic device that attaches to the skin like a bandage and enables real-time, continuous monitoring of blood pressure over extended periods.

    Unlike conventional cuff-based blood pressure monitors that use an inflatable air bladder to apply pressure to the arm, this new technology continuously measures blood pressure with a compact, flexible electronic patch, garnering global attention for its convenience and innovative design.

    Supported by SNU-Global Excellence Research Center establishment project, this collaborative study was conducted jointly with Carnegie Mellon University (U.S.) and has been published in the online edition of Advanced Functional Materials (Impact Factor 19.0, top 4.9% in JCR for Materials Science).

    Globally, only 21% of the estimated 1.3 billion people with hypertension effectively manage the condition, posing a major public health concern. However, the cuff-based blood pressure measurement method currently in widespread use is limited to one-time measurements, making continuous measurement difficult. In addition, the size of the cuff causes discomfort, making it unsuitable for long-term blood pressure monitoring during daily life. Additionally, Measurement inaccuracies can also occur due to improper positioning or stress-induced changes during use.

    Such limitations prevent detection of dynamic blood pressure changes linked to individual health status and lifestyle, which hinders early diagnosis and prevention of cardiovascular diseases. There is an urgent need for new technologies that allow patients to comfortably measure their blood pressure continuously by simply attaching a device to the skin.

    The research team that tackled this problem devised a continuous blood pressure monitoring technology based on the observation that the time it takes for electrical signals (electrocardiogram) and mechanical signals (pulse) generated simultaneously in the heart to reach the wrist varies depending on blood pressure. Electrical signals are transmitted rapidly throughout the body as soon as the heart beats, so they are detected almost immediately at the wrist. On the other hand, mechanical signals are delayed in transmission as blood is pushed out during heart contraction, so it takes some time for the wrist skin to move slightly after the heart beats.

    This time difference is directly related to blood pressure. When blood pressure is high, blood flow speed increases, shortening the time difference between the two signals. Conversely, when blood pressure is low, the time difference lengthens. Based on this principle, the research team implemented a model that continuously measures systolic and diastolic blood pressure by precisely detecting the two signals with each heartbeat and analyzing the results.

    However, it is not easy to detect subtle changes in the skin caused by blood flow. Therefore, the research team took the next step and designed an electronic device that naturally adheres to the patient’s skin using a unique material called liquid metal. Liquid metal, which remains in a liquid state even at room temperature and conducts electricity well, is suitable as a material for this electronic device because it has the same elasticity as skin.

    However, liquid metal has very high surface tension, making it extremely difficult to draw circuits precisely or create fixed shapes. To overcome this limitation, the research team devised a unique process called “laser sintering.” By using this method, which involves heating finely dispersed liquid metal particles with a laser to fuse them together, it is possible to draw circuits only at specific desired locations. Finally, the research team successfully developed a wearable electronic device for continuous blood pressure measurement that possesses excellent electrical conductivity and is easily deformable, without the need for additional chemicals, using this process.

    This electronic device has excellent electrical and mechanical performance, enabling it to accurately measure both electrocardiograms and heart rates originating from the heart. In addition, the research team confirmed through experiments that the device maintains its performance even when stretched to 700% of its original length or repeatedly stretched more than 10,000 times. Furthermore, they successfully measured the rapid rise and recovery of blood pressure before and after actual exercise, demonstrating more precise blood pressure monitoring capabilities than the existing cuff method.

    The continuous blood pressure measurement wearable electronic device developed in this study is expected to revolutionize the way we manage our health in our daily lives. Simply attaching it to the wrist allows real-time monitoring of blood pressure changes, eliminating the inconvenience of having to measure blood pressure only at hospitals or static locations as before. Especially for patients with chronic conditions like hypertension, often referred to as a “silent killer,” this electronic device provides practical assistance by enabling them to monitor their current condition anytime and anywhere.

    It can also track sudden changes or recovery in blood pressure during exercise, making it useful for personalized exercise prescriptions and fitness coaching. Furthermore, it has industrial potential as a core technology that can be integrated into various types of wearable devices, such as smartwatches, patch-type medical devices, and breathable clothing-type sensors. In the long term, it is expected to contribute to accelerating the arrival of a smart healthcare era where anyone can prevent diseases and manage their health in everyday settings rather than in hospitals.

    Professor Seung Hwan Ko, who led the study, commented, “This research challenges the conventional belief that blood pressure measurement is inconvenient and sufficient only once a day. Our system proposes a new healthcare interface capable of detecting and analyzing physiological signals noninvasively and in real time.” He added, “Given its potential applications in intensive care monitoring, workplace safety, and lifestyle health data analytics, this technology could become a practical tool for improving quality of life in the modern era.”

    Co–first authors Jung Jae Park and Sangwoo Hong are working on follow-up research to further advance biosignal-based smart sensor technology based on this study. The two researchers plan to continue their research to enhance the practicality and expandability of this technology by integrating various substrate materials, wireless communication functions, and AI-based data analysis technology.

    Source:

    Seoul National University College of Engineering

    Journal reference:

    Park, J. J., et al. (2025). Highly Sensitive Cuffless Blood Pressure Monitoring with Selective Laser‐Sintered Liquid Metal Conductors. Advanced Functional Materials. doi.org/10.1002/adfm.202505089.

    Continue Reading

  • Did Chinese authorities take a page from the Covid-19 playbook for chikungunya?

    Did Chinese authorities take a page from the Covid-19 playbook for chikungunya?

    When a drone’s camera picked up water buckets and potted plants on the balcony of a four-storey village house in Foshan – the city in Guangdong province at the centre of southern China’s chikungunya outbreak – local authorities acted quickly.

    An official visited the house but was denied entry, prompting the village’s Communist Party secretary to lead a task force to the building, knocking and shouting at the front door until the residents finally came downstairs.

    According to an article on the Nanhai district government’s official WeChat account on July 26, the team explained the hazards of breeding mosquitoes, the potential consequences of the disease, as well as the laws and regulations on pandemic prevention.

    On the top floor of the residence, the task force found “a dozen buckets containing muddy, stagnant water and, upon closer inspection, swarms of wriggling mosquito larvae”, the article said.

    In the battle against the mosquito-borne viral disease, Chinese authorities have turned to a familiar playbook, with some measures – such as quarantine, disinfection of neighbourhoods and real-name registration for fever medicine – recalling the response to Covid-19.

    Some of the more intrusive measures have sparked concerns and complaints – such as a Beijing News report about a child with a fever whose parents refused to let community workers take a blood sample on August 3.

    Continue Reading

  • Stepwise Management of Status Asthmaticus Refractory to Initial Therapy: A Case Report

    Stepwise Management of Status Asthmaticus Refractory to Initial Therapy: A Case Report


    Continue Reading

  • Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

    Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.

    FRANKFURT, Germany, Aug. 8, 2025 /PRNewswire/ — In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care. As cases continue to rise across tropical and subtropical regions, timely detection and differentiation from other arboviral infections like Dengue and Zika remain critical.

    The test, based on immunochromatographic technology, enables reliable qualitative detection of Chikungunya-specific antibodies in human serum, plasma, or whole blood. This addition strengthens Anbio’s infectious disease diagnostics portfolio and supports public health efforts in responding to emerging outbreaks.

    In parallel, Anbio is advancing the boundaries of decentralized molecular diagnostics with the launch of its new AP-100 Ultra-Fast PCR system, designed to bring laboratory-grade testing capabilities directly to the point of care.

    “Outbreaks demand speed. The AP-100 collapses hours of traditional PCR into minutes, without compromising accuracy,” said Michael Lau, CEO of Anbio Biotechnology.

    The AP-100 utilizes an advanced microfluidic thermal cycling system combined with high-efficiency enzymatic amplification chemistry, enabling direct processing of swab samples without the need for nucleic acid extraction. Its integrated design streamlines sample-to-result workflows, making it well-suited for deployment in both centralized laboratories and decentralized, point-of-care environments.

    Key highlights:

    • 15-minute PCR results from raw sample to answer
    • Extraction-free workflow with no hazardous reagents
    • Compact 668g device for mobile or near-patient testing
    • Broad pathogen coverage, including COVID-19, Flu A/B, RSV, MP, and ADV
    • Lab-comparable accuracy validated against mainstream PCR platforms

    While initially focused on respiratory infections, the AP-100 is designed as a flexible molecular platform. In line with its global infectious disease strategy, Anbio is expanding the assay portfolio to include tests for tuberculosis (TB) and human papillomavirus (HPV), extending its role from rapid outbreak response to sustained disease management.

    “Whether it’s vector-borne fevers or respiratory pandemics, we believe diagnostics should move as fast as the threat,” Lau added.

    With its combination of speed, mobility, and lab-grade precision, Anbio’s new-generation POCT PCR system strengthens healthcare capacity in both well-resourced and resource-limited settings, advancing global preparedness for infectious disease threats.

    About Anbio Biotechnology

    Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, rapid testing and veterinary diagnostics. With operations across multiple regions, the company works to enhance the availability of reliable and timely diagnostics, supporting better decision-making in healthcare settings worldwide.

    For more information about Anbio Biotechnology, follow us for the latest news and updates.

    SOURCE Anbio Biotechnology

    Continue Reading

  • ‘Road to Zero’ strategy finalised to eradicate polio – Newspaper

    ‘Road to Zero’ strategy finalised to eradicate polio – Newspaper

    LAHORE: The national and provincial leaderships have reaffirmed their commitment to eliminate polio from Pakistan by finalising a comprehensive “Road to Zero” strategy during a two-day National Polio Management Team (NPMT) meeting, which concluded here on Friday.

    Chaired by Prime Minister’s Focal Person on Polio, Ms Ayesha Raza Farooq, the meeting was also attended by Emergency Operations Centre (EOC) coordinators from all four provinces, as well as representatives from Azad Jammu & Kashmir (AJK) and Gilgit-Baltistan (GB).

    Senior officials from the federal government, partner agencies and development organisations were also present.

    Presiding over the meeting, Ms Farooq paid rich tribute to the frontline polio workers, acknowledging their dedication despite persistent challenges such as refusals, misinformation, and access issues in high-risk areas.

    “Despite the odds, our frontline workers are doing a remarkable job. The NPMT has provided all stakeholders an opportunity to openly discuss and deliberate on the challenges facing the programme and strategise actionable solutions,” she remarked.

    Expressing concern over the evolving epidemiological trends, she noted that although serious challenges remain, substantial progress has been made in areas such as quality surveillance, campaign performance, and risk communication.

    She called on all stakeholders, including the government departments and international partners, to work with renewed commitment and collaboration.

    “This year, we will approach things differently. Out-of-the-box solutions must be applied to reach every missed child and eradicate polio once and for all,” she stated.

    Ms Farooq emphasised the importance of the pre-campaign phase of Supplementary Immunisation Activities (SIAs) to ensure successful outcomes and lasting impact.

    She also highlighted the growing synergy between the Polio Eradication Initiative (PEI) and the Expanded Programme on Immunisation (EPI), terming it a pivotal element for polio eradication.

    Addressing specific regional challenges, she urged the Khyber Pakhtunkhwa (KP) team to intensify efforts to overcome security-related barriers, particularly in south KP, which remains one of the most challenging zones for the programme.

    While maintaining focus on traditional polio hotspots and virus reservoirs, the focal person cautioned stakeholders against neglecting other areas that currently appear stable.

    “We must keep our foot on the accelerator in every part of the country. Success can only be achieved by working as one cohesive team,” she stressed.

    Ms Farooq also reflected on the country’s earlier gains, which had brought Pakistan extremely close to polio eradication. She urged everyone to learn from past experiences, close the remaining gaps and cross the final threshold.

    She called for transparent and meaningful accountability at all levels to ensure efficiency and credibility. While acknowledging the reality of resource constraints, she encouraged the programme to optimise existing resources and improve coordination among partners and government departments.

    In her closing remarks, she appreciated the tireless efforts of provincial coordinators and their teams, paid tribute to polio workers across the country and acknowledged the silent heroes of the programme, including personnel from law enforcement agencies, for ensuring access and security in difficult areas.

    Pakistan remains one of only two countries in the world, along with Afghanistan, where wild poliovirus transmission has never been interrupted. However, the country has made significant strides in reducing polio cases, thanks to the relentless efforts of frontline workers, community mobilisers and the support of the government and international partners.

    Published in Dawn, August 9th, 2025

    Continue Reading

  • Two siblings among latest child deaths as devastating outbreak grips Pacific

    Two siblings among latest child deaths as devastating outbreak grips Pacific

    Two siblings are among the latest deaths in the Pacific nation of Samoa, amid a devastating outbreak of dengue fever. A total of five children have succumbed to the mosquito-borne virus in recent months, with the last three deaths occurring in the space of just four days.

    A nine-year-old boy and his two-year-old brother from Mulifanua in Upolu became the fourth and fifth victims of the virus, passing away within days of each other.

    According to the boys’ grandmother, the older brother was given Panadol in the days before his death on July 30 after showing symptoms of dengue fever.

    After waiting hours to be seen at their closest medical centre, an ambulance was eventually called to transport him to the main hospital, but his “heartbeat dropped” just 10 minutes into the journey.

    They returned back to the clinic, but the child could not be saved.

    Tragically, his younger brother passed away several days later.

    Men dressed in white PPE spray gardens and building in Samoa for mosquitoes amid a spike in dengue cases.

    Workers spray for mosquitoes to help fight the growing number of dengue cases in Samoa. Source: Ministry of Health Samoa

    The three other deaths include a five-year-old girl who died on July 29, an eight-year-old girl who died on July 13 and a 12-year-old boy who died in April after being flown to New Zealand for medical treatment.

    Prime Minister Fiamē Naomi Mataʻafa this week urged parents “not to wait until it is too late” to seek medical attention for children affected by dengue fever.

    “It is important to heed advice from the Ministry of Health. For parents and guardians, please seek immediate medical assistance if your child develops dengue fever symptoms,” she said at a press conference on Monday.

    “Do not wait until it is too late. Early treatment can save lives.”

    Samoa’s Ministry of Health released their latest dengue report on Thursday, confirming four dengue-related deaths and one probable death awaiting confirmation. A further 1446 clinically diagnosed cases were reported from July 28 to August 3.

    The spike in dengue cases has caused all schools across Samoa to be closed for another week, heavily disrupting the start of term 3.

    Samoa, along with Fiji, Tonga, the Cook Islands and Kiribati are all in the grips of dengue fever outbreaks. Other nations have also reported cases, though haven’t officially announced an outbreak. These include Hawai’i, French Polynesia, American Samoa, Nauru and Tuvalu.

    The mosquito-borne virus has similar symptoms to a bad flu or Covid virus, which can make it difficult to diagnose without a blood test. Symptoms typically include sudden fever, headache, muscle pain, vomiting and a faint red rash.

    Three maps of the Samoan island of Upolu, showing dengue fever hotspots and planned fumigation.Three maps of the Samoan island of Upolu, showing dengue fever hotspots and planned fumigation.

    A large-scale fumigation campaign has been launched in Upolu, targeting schools, businesses and hotspot villages. Source: Government of Samoa

    In Samoa, a staggering 71 per cent of dengue cases are in children younger than 15 years old.

    Dr Mark Jacobs, WHO Representative to the South Pacific and Director of Pacific Technical Support, recently told Yahoo News there’s a reason why young people are more highly represented in the statistics.

    “Because being infected with a strain of dengue usually provides lifelong immunity against that strain, children can be at much higher risk of being infected when the strain is reintroduced into the country,” he said.

    “Many adults would have been infected previously, meaning they are protected from reinfection with that strain.”

    There are four strains of dengue, with two currently in the Pacific. Once someone recovers from the disease, they generally get life-long immunity — but only to that strain.

    The WHO advises that even a bottle cap can contain enough water for a mosquito to breed, and urges locals to do their part to clean up any potential mosquito breeding sites. Drains, gutters, bottles, buckets, wheelbarrows and even spare tyres could all collect water and turn into a breeding ground.

    Do you have a story tip? Email: newsroomau@yahoonews.com.

    You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.


    Continue Reading

  • Only one in ten people report side effects, Healthcare Improvement Scotland warns

    Only one in ten people report side effects, Healthcare Improvement Scotland warns

    More should be done to raise awareness and promote use of the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card scheme, according to a report from Healthcare Improvement Scotland (HIS).

    The report, published in June 2025, found that that just 10% of people who experienced medication side effects reported them through the Yellow Card scheme.

    As part of the report, HIS surveyed Citizens’ Panel members on their public views concerning medicine safety, long-term conditions and preconception health and care.

    Of the 563 responses received by post, email or over the phone, more than half of respondents (57%) said they had experienced a side effect or unintended effect from a medicine, the report found.

    In addition, more than three-quarters of respondents (84%) had spoken to a doctor, nurse or pharmacist about medication side effects, while almost one-third of respondents (29%) had spoken to family and friends.

    It is possible that low use of the scheme could be because people viewed their side effects as not significant enough to report; however, there could also be an opportunity to increase awareness of the scheme, the report said.

    In the report, HIS recommends taking “action to promote and support public awareness of the Yellow Card scheme to improve underreporting of medicines’ side effects” and to “improve how NHS Scotland draws learning from the data that are collected and analysed through the Yellow Card scheme”.

    On 7 August 2025, Laura Fulton, chief pharmacist of HIS, said the scheme is “vital to improve our understanding of medicines and safeguard patients”.

    “I would encourage patients, members of the public and healthcare professionals to proactively utilise the Yellow Card scheme and report any concern as soon as they can,” she added.

    Laura Wilson, director for Scotland at the Royal Pharmaceutical Society, commented: “It is extremely important that the public are aware of the ways they can report side or unintended effects from medicines. This helps to raise awareness of the potential effects of medicines and improves medicines safety.

    “The Yellow Card scheme is a fantastic initiative, which makes this process accessible and straightforward. I would encourage everyone to make use of it.

    “Yellow Card representatives will be exhibiting at our RPS Scottish conference later this month, and we look forward to engaging with them and learning more about their important work.”

    In a letter published in The Pharmaceutical Journal in June 2025, pharmacists Rajesh Jethwa and Nathaniel Addo said that in a small survey of 25 healthcare professionals in East London, a clear majority (84% (n=21) were aware of the Yellow Card scheme.

    However, 76% of respondents (n=19) had never reported a side effects through it, which suggests underutilisation of the scheme.

    Continue Reading

  • Bessel-Hagen Disease: A Case Report of a Rare Disease

    Bessel-Hagen Disease: A Case Report of a Rare Disease


    Continue Reading